An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer

BACKGROUND: The cancer stem cell (CSC) hypothesis has important clinical implications for cancer therapeutics because of the proposed role of CSCs in chemoresistance. The aim of this study was to investigate changes in the CSC populations before and after primary systemic therapy (PST) and their pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, H E, Kim, J H, Kim, Y J, Choi, S Y, Kim, S-W, Kang, E, Chung, I Y, Kim, I A, Kim, E J, Choi, Y, Ryu, H S, Park, S Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111169/
https://www.ncbi.nlm.nih.gov/pubmed/21559013
http://dx.doi.org/10.1038/bjc.2011.159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111169/
https://www.ncbi.nlm.nih.gov/pubmed/21559013
http://dx.doi.org/10.1038/bjc.2011.159

Ejemplares similares